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Cartilage Imaging
Introduction
The early degenerative changes in osteoarthritic (OA) artic-
ular cartilage are well documented in the literature (e.g., 
glycosaminoglycan [GAG] loss, tissue softening, swelling, 
and chondrocyte hypertrophy).1-4 Unfortunately, clinicians 
are not able to accurately detect or quantify these tissue 
changes in the clinic. Standard-of-care imaging modalities 
such as plain radiography and joint arthroscopy are capable 
of diagnosing moderate- to late-stage OA, manifested as 
macroscopic cartilage damage (e.g., volume loss, lesions, 
fissures, and fibrillation). These imaging strategies, how-
ever, provide an occluded view of the earliest signs of carti-
lage pathology. This lack of sensitive imaging capabilities 
represents lost opportunities for clinicians to guide treat-
ment before damage becomes widespread or severe, with 
little recourse short of joint arthroplasty. The development 
of a sensitive, noninvasive or minimally invasive method 
for detecting early changes in cartilage properties would 
provide opportunities for clinicians to diagnose and treat 
OA earlier and, thus, minimize or prevent OA progression.
Among the methods for early OA diagnosis, magnetic 
resonance imaging (MRI) and computed tomography (CT) 
are two of the most common imaging techniques.5 Contrast-
enhanced techniques, such as delayed gadolinium-enhanced 
magnetic resonance imaging of cartilage (dGEMRIC) and 
iodinated contrast-enhanced computed tomography (CECT), 
rely on diffusion and partitioning of mobile ionic contrast 
agents into cartilage in proportion to the tissue’s anionic 
fixed charge density (FCD).6-14 Even though modern MRI 
scanners provide sufficient in-plane resolution (up to 400 
µm) for cartilage assessment, MRI suffers from several 
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Abstract
Objective. The aim of this study was to investigate whether the concentration of the anionic contrast agent ioxaglate, as 
quantitated by contrast-enhanced computed tomography (CECT) using a clinical cone-beam CT (CBCT) instrument, reflects 
biochemical, histological, and biomechanical characteristics of articular cartilage imaged in an ex vivo, intact human knee joint. 
Design. An osteoarthritic human cadaveric knee joint (91 years old) was injected with ioxaglate (36 mg I/mL) and imaged 
using CBCT over 61 hours of ioxaglate diffusion into cartilage. Following imaging, the joint surfaces were excised, rinsed 
to remove contrast agent, and compressive stiffness (equilibrium and instantaneous compressive moduli) was measured 
via indentation testing (n = 17 sites). Each site was sectioned for histology and assessed for glycosaminoglycan content 
using digital densitometry of Safranin-O stained sections, Fourier transform infrared spectroscopy for collagen content, 
and morphology using both the Mankin and OARSI semiquantitative scoring systems. Water content was determined using 
mass change after lyophilization. Results. CECT attenuation at all imaging time points, including those <1 hour of ioxaglate 
exposure, correlated significantly (P < 0.05) with cartilage water and glycosaminoglycan contents, Mankin score, and both 
equilibrium and instantaneous compressive moduli. Early time points (<30 minutes) also correlated (P < 0.05) with collagen 
content and OARSI score. Differences in cartilage quality between intrajoint regions were distinguishable at diffusion 
equilibrium and after brief ioxaglate exposure. Conclusions. CECT with ioxaglate affords biochemical and biomechanical 
measurements of cartilage health and performance even after short, clinically relevant exposure times, and may be useful 
in the clinic as a means for detecting early signs of cartilage pathology.
Keywords
cartilage imaging, contrast enhanced computed tomography, osteoarthritis, cone beam computed tomography
392 CARTILAGE 8(4) 
disadvantages including a lack of rapid 3-dimensional data 
acquisition with isotropic voxel size and high resolution, 
long acquisition times, high cost, and often long queuing 
times in the clinic. CECT may provide a feasible alternative 
for dGEMRIC since images are acquired with very short 
acquisition times, it is less expensive, and imaging data can 
be acquired at high enough resolution to enable multiplanar 
reconstruction and 3-dimensional data representations. In 
particular, cone-beam CT (CBCT) scanners for imaging the 
extremities provide high spatial resolution (≤200 µm) with 
isotropic voxels and low patient radiation exposure (≤11 µSv 
per scan15,16), and represent a significant instrumentation 
advancement for use in the clinic.
Since the conception of CECT of articular cartilage, the 
technique has been applied to a variety of species for the 
quantification of cartilage thickness, GAG content, equilib-
rium modulus, and coefficient of friction.13,17-23 Recently, 
studies have explored using the partitioning of an anionic 
contrast agent, well before diffusion equilibrium, and the 
resulting CECT attenuation to reflect cartilage properties 
ex vivo.15,24 A 2011 study by Siebelt et al.25 showed that 
clinical CECT attenuation from intact human cadaver 
knees following ioxaglate injection correlated strongly 
with equilibrium partitioning of ioxaglate measured using 
micro-CT. Interestingly, this strong correlation (R2 = 0.73) 
was found after only 10 minutes of contrast diffusion into 
the cartilage surfaces. A report from 2012 presents a simi-
lar result in which clinical CECT attenuation, after brief 
ioxaglate exposure, strongly correlated with equilibrium 
micro-CT attenuation.26 These studies are encouraging for 
CECT, since in vivo diffusion equilibrium may be difficult 
to reach between articular cartilage and the surrounding 
contrast agent in the synovial fluid within a clinically rel-
evant time frame. This is especially true for thicker carti-
lage (e.g., from human knee joints and large animal 
models), which require an extended time to reach equilib-
rium (>8 hours7,8) relative to the time scale over which the 
contrast solution effluxes from the synovial joint space (the 
contrast agent’s half-life in the joint space is ~30 to 60 min-
utes following intra-articular injection24). However, the 
aforementioned studies suggest that even pre-equilibrium 
partitioning of an anionic contrast agent may yield valuable 
information regarding cartilage properties and function, par-
ticularly GAG content but also possibly tissue permeability, 
collagen cross-linking, and compressive modulus. To date, 
however, a direct comparison has not been made between 
CECT measurements acquired using a clinical CBCT instru-
ment in an intact human knee and quantitative biochemical, 
histological, and biomechanical reference measures in 
cartilage.
Therefore, the aim of this study was to evaluate whether 
CECT using the anionic contrast agent ioxaglate reveals dif-
ferences in cartilage composition or properties between 
intrajoint regions of an ex vivo, intact human knee joint. 
Furthermore, the potential of CECT to quantitatively distin-
guish the cartilage quality is determined both at diffusion 
equilibrium and at shorter times before diffusion equilibrium 
is reached. This study addressed 2 hypotheses: CECT using 
ioxaglate would (1) produce significant correlations between 
CECT attenuation and reference measures at diffusion equi-
librium and would also (2) produce significant correlations 
following briefer, and clinically relevant, exposure times. 
Specifically, we report the (1) CBCT of an ex vivo, intact 
human knee joint; (2) morphological evaluation of the carti-
lage tissue using both the Mankin and OARSI (OsteoArthritis 
Research Society International) semiquantitative scoring 
systems; (3) diffusion profiles of ioxaglate into the cartilage; 
(4) measurement of compressive stiffness (equilibrium com-
pressive modulus, instantaneous compressive modulus) via 
indentation testing; (5) histological assessment of GAG con-
tent using digital densitometry of Safranin-O–stained sec-
tions; and (6) determination of collagen content via Fourier 
transform infrared (FTIR) spectroscopy.
Materials and Methods
Cadaver Knee Joint
For this study, a randomly selected cadaver (n = 1, female, 
91 years) was obtained 4 days after death. The cadaver was 
1Department of Biomedical Engineering, Boston University, Boston, MA, USA
2Center for Advanced Orthopaedic Studies, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA
3Department of Applied Physics, University of Eastern Finland, Kuopio, Finland
4Diagnostic Imaging Center, Kuopio University Hospital, Kuopio, Finland
5Institute of Biomedicine, Anatomy, University of Eastern Finland, Kuopio, Finland
6Research Unit of Medical Imaging, Physics and Technology, Faculty of Medicine, University of Oulu, Oulu, Finland
7Department of Diagnostic Radiology, Oulu University Hospital, Oulu, Finland
8Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland
9Department of Orthopaedics, Traumatology and Hand Surgery, Kuopio University Hospital, Kuopio, Finland
10Department of Chemistry, Boston University, Boston, MA, USA
*These authors contributed equally to this work.
Corresponding Author:
Juuso T. J. Honkanen, Department of Applied Physics, University of Eastern Finland, POB 1627, 70211 Kuopio, Finland. 
Email: juuso.honkanen@uef.fi
Stewart et al. 393
stored at 4°C in the morgue at Kuopio University Hospital 
before the start of the experiment. The study protocol was 
reviewed and accepted by the ethical committee of Kuopio 
University Hospital (Permission: 58//2013).
CECT Imaging
The right knee joint of the cadaver was imaged ex vivo 
using a clinical peripheral CBCT scanner (Verity, Planmed 
Oy, Helsinki, Finland) (Fig. 1D). First, the knee joint was 
imaged without contrast agent (i.e., baseline scan). After the 
baseline scan, an orthopedic surgeon intra-articularly 
injected 30 mL of the anionic contrast agent ioxaglate (q = 
−1, M = 1269 g/mol, Hexabrix, Mallinckrodt Inc., St. Louis, 
MO, USA). The contrast agent was diluted to an isotonic 
concentration (36 mg I/mL) with phosphate buffered saline 
(PBS) including penicillin–streptomycin (100 units/mL 
penicillin, 100 µg/mL streptomycin; EuroClone, Siziano, 
Italy), antimycotic agent (Gibco Fungizone Antimycotic, 
250 µg/mL amphotericin B, 205 µg/mL sodium deoxycho-
late; Life Technologies, Carlsbad, CA, USA) and inhibitors 
of proteolytic enzymes (5 mM ethylenediaminetetraacetic 
acid disodium salt [EDTA; VWR International, Fontenay, 
France] and 5 mM benzamidine hydrochloride hydrate 
[Sigma-Aldrich Inc., St. Louis, MO, USA]). After the injec-
tion, the knee joint was flexed and extended 30 times in a 
full range of motion to allow the contrast agent to distribute 
evenly throughout the joint.
The diffusion of the contrast agent into the articular car-
tilage was imaged at 13 time points (10, 20, 30, 40, 50 min-
utes, and 1, 2, 4, 6, 9, 16, 36, 61 hours) of ioxaglate exposure. 
To compensate for the contrast agent diffusion out of the 
joint cavity and to maintain a steady contrast agent solution 
in the joint space, an additional 10 mL of contrast agent was 
injected after 16 and 35 hours after the initial injection. An 
isotropic voxel size of 200 × 200 × 200 µm3, 96 kV tube 
voltage, 12 mA tube current, 20 ms pulse length, and 500 
projections were applied when acquiring the CBCT images.
After CBCT imaging, an orthopedic surgeon opened the 
joint and excised the articulating surfaces (cartilage with ~2 
cm of bone underneath; Fig. 1A and B) with an oscillating 
saw. The excised pieces were imaged again using CBCT in 
order to facilitate image registration and segmentation. The 
excised pieces were wrapped in gauze dampened with PBS 
Figure 1. Excised joint surface pieces (n = 7) in sagittal (A) and coronal (B) planes (PS = patellar surface, LCA = lateral condyle 
anterior part, MCA = medial condyle anterior part, LT = lateral tibia, MT = medial tibia, MCP = medial condyle posterior part). 
(C) Illustration of the patella with indentation sites marked (d = 2 mm, red circles). A 1 × 1 cm2, full-thickness piece was harvested 
symmetrically around each indentation site, and was subsequently halved through the indentation site for water content determination 
and histology (0.5 × 1 cm2 each). (D) A clinical peripheral cone beam computed tomography (CBCT) scanner (Verity, Planmed Oy, 
Helsinki, Finland) used in this study.
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and including the antibiotic/antimycotic/protease inhibitor 
cocktail and frozen at −20°C until the biomechanical mea-
surements were conducted.
Biomechanical Measurements
Before the biomechanical measurements, the contrast agent 
was washed out by immersing the excised pieces in isotonic 
PBS including the antibiotic/antimycotic/protease inhibitor 
cocktail for 48 hours to remove the contrast agent. 
Subsequently, the cartilage thicknesses at 17 locations (3 
from the patella, 3 from the patellar surface, 4 from the 
anterior part of medial condyle, 2 from the posterior part of 
medial condyle, 2 from the anterior part of lateral condyle, 
2 from the medial tibia and 1 from the lateral tibia) were 
precisely determined via micro-CT imaging (SkyScan 
1172, Bruker microCT, Kontich, Belgium) with an isotropic 
voxel size of 35 × 35 × 35 µm3 and 100 kV tube voltage.
The excised pieces were glued to the bottom of a mea-
suring chamber filled with PBS. For each indentation loca-
tion the chamber angle was adjusted with a goniometer to 
make the contact surface of the cartilage perpendicular to a 
cylindrical flat-ended steel indenter (d = 1.05 mm). A stress-
relaxation protocol was implemented using a ramp rate of 
100%/s, 4 compressive steps (4 × 5% of cartilage thickness) 
and a relaxation criterion of 20 minutes after each step. The 
test was conducted using a custom-made material testing 
system27 including a high-precision load cell (Model 31/
AL311AR, Honeywell, Columbus, OH, USA; resolution, 
0.005 N) and an actuator (PM1A1798, Newport Corporation, 
Irvine, CA, USA; resolution, 0.1 µm). The equilibrium (the 
stress–strain ratio (linear fit) from step 2 to 4) and instanta-
neous moduli (step 2) were calculated with Poisson’s ratios 
of ν = 0.1 and ν = 0.5, respectively, in accordance with 
Hayes et al.28
Histology and Compositional Analyses
After the biomechanical measurements, a 1 × 1 cm2 sample 
(full cartilage thickness with ~5-10 mm attached subchon-
dral bone) was cut symmetrically around each indentation 
site (Fig. 1C). Subsequently, the samples were halved 
through the indentation site. One half was processed for his-
tological analysis, and in the other half the cartilage was 
sharply transected from the subchondral bone using a razor 
blade and processed for analysis of water content. The 
water contents were determined from the difference between 
the wet and dry weights before and after lyophilization.
For the histological analysis, the samples were fixed in 
10% formalin, decalcified, processed in graded alcohol solu-
tions, embedded in paraffin, and cut perpendicularly to the 
cartilage surface across the sample face containing the 
indentation location. To reveal the spatial GAG distribution 
in cartilage, 3-µm thick sections were stained with Safranin-O 
and measured utilizing quantitative digital densitometry 
(DD).29 The measurement system consisted of a light micro-
scope (Leitz Wetzlar, Wetzlar, Germany) using monochro-
matic light (λ = 492 ± 5 nm) and a Peltier-cooled 12-bit CCD 
camera (CH250, Photometrics, Tucson, AZ, USA). The sys-
tem was calibrated with neutral density filters (Schott, 
Mainz, Germany) covering an optical density (OD) range 
from 0 to 2. The average GAG content for each sample was 
determined at the center of each section within a 1-mm wide 
and full-thickness region of interest (ROI). Three sections 
per sample site were analyzed and averaged.
The spatial distribution of collagen was measured by 
means of FTIR spectroscopy (Hyperion 3000, Bruker 
Corporation, Billerica, MA, USA) on 5 µm sections adja-
cent to the ones used in DD. After the paraffin removal, the 
sections underwent enzymatic removal of GAGs using 
hyaluronidase (400-1000 U/mg solid hyaluronidase type 
I-S, Sigma-Aldrich, St. Louis, MO, USA) and papain 
(ACROS Organics, Fisher Scientific International, Inc., 
Hampton, NH, USA). The collagen content was estimated 
as the peak area of amide I region (1595-1720 cm−1) using a 
pixel size of 20 × 20 µm2 and a spectral resolution of 8 cm−1. 
Finally, the average collagen content at the center of the 
section (corresponding ROI) was determined similarly as 
with the average GAG content from the DD.
Mankin and OARSI Grading
OA severity in the measurement sites was evaluated accord-
ing to the modified Mankin30 and OARSI grading systems.31 
In the modified Mankin grading, abnormalities in structure 
(0-6 points), cellularity (0-3 points) and Safranin-O staining 
(0-4 points) were assessed up to a maximum score of 13 
points. In the OARSI grading, the integrity of the cartilage 
matrix was evaluated with scores of 0 to 6.5 (in intervals of 
0.5 points). In both grading systems, three Safranin-O–
stained sections per measurement site were scored. The 
final score for each section was calculated as the average of 
three independent assessors.
CECT Image Analysis
The CECT data were analyzed using Analyze software (v. 
11.0, AnalyzeDirect, Inc., Stilwell, KS, USA). Each imaging 
time point was co-registered with each excised region imaged 
with CBCT and the cartilage in each region was manually 
segmented from the subchondral bone. Furthermore, ROIs 
with full cartilage thickness corresponding to the indentation 
measurement (ROI diameter = 4 × r of the indenter tip) and 
the section assessed for water content (5 mm × 10 mm rect-
angle) were extracted (Fig. 1C). The ROIs were applied to 
the co-registered image series and the mean X-ray attenua-
tion in Hounsfield units (HU) was extracted from each ROI 
at each time point. The mean X-ray attenuation of each ROI 
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at each time point was corrected by subtracting the attenua-
tion of the noncontrast (baseline) scan. Tissue water content 
was compared with the mean attenuation value of the corre-
sponding ROI, while the biomechanical and histological 
measures of cartilage quality were compared against the 
mean attenuation of the indentation ROI.
Statistical Analyses
The relationships between reference parameter values and 
CECT attenuation were evaluated using Pearson’s correla-
tion analysis. The normality of the measures was deter-
mined using Shapiro-Wilk test. Statistical analyses were 
conducted using SPSS (SPSS v. 21.0.0.0, SPPS Inc., IBM 
Company, Armonk, NY, USA).
Results
Descriptive statistics for the excised cartilage regions are 
shown in Table 1. Cartilage quality varied across the intra-
joint regions, with particularly large variations in equilib-
rium and instantaneous compressive moduli (relative 
standard deviations = 75% and 97%, respectively) com-
pared with the biochemical and histological reference mea-
sures of water, GAG, and collagen contents, Mankin and 
OARSI scores, and tissue thickness (relative standard devi-
ations between 4% and 49%).
Ioxaglate diffused into the cartilage in all 17 examined 
regions. Cartilage attenuation increased in each region up 
until 36 hours of diffusion; some regions increased more 
between 36 and 61 hours, and some decreased (Fig. 2). The 
slope of the diffusion trajectory for each region through 
early, clinically relevant time points (10 minutes to 2 hours) 
correlated with cartilage water content (r = 0.68, P = 0.003), 
but no other reference parameter.
CECT using ioxaglate enabled visual and quantitative 
distinction of cartilage quality between intrajoint regions 
at both early and late time points during contrast agent 
exposure (Figs. 3 and 4). Specifically, the CECT attenua-
tion correlated significantly (P < 0.05) with the Mankin 
score, water content, OD, and equilibrium and instanta-
neous moduli both at early time points (<2 hours) and at 
36 hours (Fig. 4). The CECT attenuation also correlated 
significantly with collagen content, determined via FTIR, 
and OARSI score at 10 minutes (r = −0.59, P = 0.012 and 
r = 0.53, P = 0.028, respectively) and 20 minutes (r = 
−0.61, P = 0.010 and r = 0.58, P = 0.014, respectively) 
time points (Fig. 4). In addition, the CECT attenuation 
after additional contrast agent injections correlated sig-
nificantly with the OARSI score (16 hours, r = 0.50, P = 
0.040; 36 hours, r = 0.52, P = 0.034) (Fig. 4). The X-ray 
attenuation in CBCT images acquired within clinically 
relevant time frames (10-120 minutes) correlated moder-
ately (0.65 < r < 0.91, P < 0.005) with those at later time 
points (16-61 hours).
Discussion
Given the need for early diagnosis of OA, imaging methods 
that can provide information on articular cartilage thickness, 
number, locations and severity of lesions, and fibrillation 
along with assessment of GAG content and mechanical 
properties are of significant interest. CECT is an emerging 
technique for imaging cartilage that offers significant prom-
ise in this area. In fact, knee CT arthrography is already a 
clinical procedure, performed in the presence of anionic or 
nonionic contrast agents, for assessing joint morphology. 
Knee CT arthrography enables identification of variations in 
cartilage thickness which may be indicative of lesions, and a 
recent report suggests that delayed CBCT arthrography (i.e., 
Table 1. Descriptive Statistics for Human Knee Cartilage Regions Imaged With Ioxaglate Using Cone-Beam Computed Tomography 
(CBCT).
n Mean SD Minimum Maximum
CECT attenuation at 40 min (HU) 17 89.5 33.1 55.9 182.5
CECT attenuation at 36 h (HU) 17 201.9 71.6 106.9 381.8
CECT attenuation at 61 h (HU) 17 213.9 79.8 111.9 396.5
Water content (%, wet weight) 17 78.6 3.2 74.7 85.4
Equilibrium modulus (MPa) 17 0.53 0.40 0.04 1.40
Instantaneous modulus (step 2) (MPa) 17 2.64 2.55 0.13 9.15
Optical density 17 1.16 0.21 0.66 1.44
Diffusion slope, 10-120 min (HU/h) 17 10.69 12.35 –2.08 40.50
Mankin score 17 5.18 1.96 2.56 8.67
OARSI score 17 2.54 1.25 0.44 4.17
FTIR (AU) 17 18.5 2.5 14.0 23.3
Cartilage thickness (mm) 17 1.94 0.44 1.30 2.93
CECT = Contrast-enhanced computed tomography; FTIR = Fourier transform infrared; OARSI = OsteoArthritis Research Society International.
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in vivo CECT) may be additionally useful for diagnosing 
cartilage degeneration.15
CBCT scanners represent a significant advancement in 
CT imaging technology with specific benefits for joint 
imaging. Even though CT imaging uses ionizing radiation, 
modern CBCT scanners provide high-resolution images 
with isotropic voxel size, short acquisition time, and a much 
more acceptable radiation dose (25% to 33% of that of heli-
cal CT16,32). Furthermore, flexible gantry movements allow 
supine and weightbearing imaging, which is advantageous 
for functional joint assessment.
In this study, CBCT of an intact human cadaver knee was 
obtained in the presence of ioxaglate at both short and long 
exposure times. This is the first study to report significant 
correlations between CECT attenuation obtained utilizing a 
clinical CBCT scanner and biochemical, histological and 
biomechanical measures of cartilage structure and perfor-
mance. During the clinically feasible time frame (10 min-
utes to 2 hours), CECT attenuation correlated with tissue 
water and GAG contents, Mankin score, and equilibrium 
and instantaneous compressive moduli. Collagen content 
and OARSI score were found to correlate with CECT atten-
uation at 10 and 20 minutes, but not 30 minutes to 2 hours 
of contrast exposure. This result may be due to the OARSI 
score’s focus on surface integrity, which is likely to influ-
ence initial diffusion kinetics. Likewise, the effect of colla-
gen content on CECT attenuation seemed to be only 
influential at very early time points.
CECT attenuation in human cartilage also correlated 
with tissue water and GAG contents, Mankin score, and 
equilibrium and instantaneous compressive moduli at the 
later diffusion time points (16 and 36 hours of contrast 
agent exposure). Collagen content did not correlate with the 
CECT attenuation at these time points. However, the 
OARSI score did correlate, likely because these measure-
ments were made directly following subsequent joint injec-
tions, allowing surface properties, reflected in the OARSI 
score, to mediate contrast agent uptake.
The strength and significance of the correlations 
decreased between CECT attenuation and all of the refer-
ence measures after 36 hours of diffusion. For example, no 
statistical significance (P = 0.072) was found for the CECT 
attenuation at the 61-hour time point in comparison with 
GAG content. This is probably due to the contrast agent 
effluxion from the joint space during the relatively long 
interval (25 hours) between the last injection and the last 
imaging time point.
Additionally, the very early time point attenuation, 
even following just 10 minutes of contrast agent expo-
sure, correlated significantly with the attenuation at later 
time points (16-61 hours), which is in line with previous 
reports.25,26 These results are important, because they sug-
gest that pre-equilibrium CECT measurements may yield 
quantitative estimates of cartilage quality. However, it is 
important to note that, while correlative to GAG content, 
the concentration of ioxaglate in the cartilage far prior to 
equilibrium is not measuring FCD (GAG content) directly, 
but likely by way of a covariable. For instance, at early 
diffusion times, contrast partitioning is probably strongly 
influenced by the changes in the steric hindrance (intact 
vs. impaired) of the matrix and tissue water content.7,33,34 
In fact, in this study we found that the rate of ioxaglate 
uptake between 10 minutes and 2 hours of exposures 
(slope of the diffusion trajectories) correlated with water 
content. Certainly, ioxaglate appears to partition in 
Figure 2. Diffusion curves showing the increase in contrast-
enhanced computed tomography (CECT) attenuation for all 
17 examined regions (MCA = medial condyle anterior part, 
P = patella, MT = medial tibia, LT = lateral tibia, PS = patellar 
surface, MPC = medial condyle posterior part, LAC = lateral 
condyle anterior part) at early, clinically relevant time points (A) 
and the complete time series (B). Two representative regions, 
from the anterior part of medial condyle (MCA) and medial 
tibia (MT), are identified (in boxes) and shown as color maps in 
Figure 3. The gray vertical dashed lines represent time points 
(16 and 36 hours) when an additional 10 mL of ioxaglate was 
injected into the knee joint.
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proportion to GAG just as well at pre-equilibrium (and 
very early) time points, which calls into question what 
ioxaglate is actually measuring at these early time points 
(times at which the agent has not even interacted with the 
majority of the tissue’s negative charges in the middle and 
deep zones). Even though early time points do not directly 
Figure 3. (Left) Contrast-enhanced computed tomography (CECT) attenuation color maps highlight differences in ioxaglate uptake 
at 40 minutes and 36 hours of diffusion. (Right) Healthy, intact cartilage (top) has greater Safranin-O staining for glycosaminoglycans 
(GAGs) and obtains less ioxaglate uptake at 40 minutes and at 36 hours relative to degenerated cartilage (bottom).
Figure 4. Pearson correlation coefficients for the relationship between cartilage contrast-enhanced computed tomography (CECT) 
attenuation and measures of cartilage composition, structure and function (Mankin and OARSI scores, water content, collagen 
content via Fourier transform infrared (FTIR) spectroscopy, glycosaminoglycan (GAG) content via optical density (OD), equilibrium 
compressive modulus (E
eq
) and instantaneous compressive modulus (E
i
)) during early, clinically relevant time points (A) and the 
complete time series (B). Filled markers represent statistically significant (P < 0.05) correlations and open markers represent non–
statistically significant relationships.
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measure GAG content, the early measurements still 
clearly reflect the condition of the cartilage internal struc-
ture (i.e. degeneration), as was recently suggested.15 
However, the implications of this distinction for quantita-
tive CECT measurements have not yet been adequately 
investigated to date.
Although we were able to detect existing differences in 
cartilage quality between intrajoint regions from a given 
joint image, a limitation of this study is the use of only 1 
human knee. Future experiments will assess a larger num-
ber of human knee joints to better elucidate the degree and 
sources of interjoint variability. Interjoint comparisons 
will be instructive for efforts to develop an objective car-
tilage health grading system that can be applied across 
patients. Importantly, these efforts may provide an oppor-
tunity to explore whether CECT is capable of producing 
differential diagnoses as specific as injury type (i.e., by 
examining the features of progressive OA versus posttrau-
matic degeneration).
While this experiment was conducted using an intact 
human knee joint and a clinically utilized scanner, it does 
not completely recapitulate the in vivo environment. In 
particular, contrast agent diffusion kinetics into the carti-
lage in vivo will be in competition with the rapid contrast 
efflux from the joint space, which is largely mediated by 
active vasculature in live patients. As it is generally not 
possible to harvest tissue specimens for further analysis 
from live patients following CECT imaging, the study 
design herein relied on a human cadaveric knee model as 
a close approximation. Furthermore, it is important to note 
that image acquisition at multiple time points is not gener-
ally feasible in clinical situations due to increased radia-
tion dose. A previous study15 suggested using only 2 
acquisitions: one immediately after the contrast agent 
injection and a second one 45 minutes after the adminis-
tration. The first acquisition (arthrographic image) pro-
vides for morphological inspection of the cartilage 
surfaces, revealing superficial lesions with excellent 
image contrast between cartilage and the higher-attenuat-
ing contrast agent in the joint space. Subsequently, the 
delayed image (after contrast agent is permitted to pene-
trate the cartilage) would probe and allow for the assess-
ment of internal health (e.g., degeneration).
In summary, ioxaglate-enhanced CT imaging utilizing a 
clinical CBCT scanner quantitatively indicates various bio-
chemical, histological, and biomechanical properties of car-
tilage in an intact human knee ex vivo. Furthermore, CECT 
distinguishes cartilage quality between intrajoint regions 
both at diffusion equilibrium and after brief ioxaglate expo-
sure. The latter is particularly important, and suggests that 
CECT may provide a clinically feasible technique for 
assessing cartilage quality in human patients. Thus, this 
study represents an important step in the development of a 
sensitive, minimally invasive technique for early diagnosis 
and monitoring of OA.
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